The Pharmacy Times® IVIG Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.
October 7th 2024
Though both treatments come with positives and negatives, ultimately, individual patient clinical presentation and accessibility will determine the proper treatment for myasthenic crisis.
Unveiling the Impact of Childhood Eczema: A Guide to Moderate-Severe Pediatric Atopic Dermatitis
1.0 Credit / Dermatology, Immunology
View More
Revolutionizing Pediatric Atopic Dermatitis Treatment With Targeted Biologics
1.0 Credit / Dermatology, Immunology
View More
Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intrav...
1.0 Credit / Immunology, Rare Diseases
View More
Maximizing the Potential of Biologics in Moderate to Severe Pediatric Atopic Dermatitis: The Expertise of the ...
1.0 Credit / Dermatology, Immunology
View More
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
1.5 Credits / Allergy, Immunology
View More
Best Practices for Optimizing Biologic Therapy Management for Moderate to Severe Atopic Dermatitis in Children
1.5 Credits / Dermatology, Immunology
View More
Integrating Biologic Therapy Into Clinical Practice for the Management of Eosinophilic Esophagitis
1.5 Credits / Gastroenterology, Immunology
View More
The Expertise of the Specialty Pharmacist in Pediatric Eosinophilic Esophagitis
1.0 Credit / Gastroenterology, Immunology
View More
Understanding the Burden of Eosinophilic Esophagitis in Children
1.0 Credit / Gastroenterology, Immunology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Emerging Biologic Therapy for the Management of Eosinophilic Esophagitis in Children
1.0 Credit / Gastroenterology, Immunology
View More
Optimizing Inflammatory Bowel Disease Treatment: A Pharmacist's Guide to Biologics and Monoclonal Antibodies
1.0 Credits / Gastroenterology, Immunology
View More
Navigating the Complexities of Biologic Therapy for Moderate to Severe Atopic Dermatitis in Children: The Impa...
1.5 Credit / Dermatology, Immunology
View More
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
1.5 Credits / Dermatology, Immunology
View More
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Kno...
1.5 Credits / Immunology, Allergy
View More
Reducing Barriers to the Integration of Biologic Therapy in the Management of Pediatric Moderate to Severe Ast...
1.5 Credits / Immunology
View More
Strategies for Integrating Biologic Therapy Into the Management of Eosinophilic Esophagitis
1.5 Credits / Immunology, Gastroenterology
View More
Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-B...
1.5 Credits / Immunology
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
1.0 Credit / Immunology, Neurology
View More
An Overview of Disease Burden Associated With COPD
1.0 Credit / Immunology, Pulmonology
View More
Biologic Therapy for the Management of Eosinophilic Esophagitis in Children: The Evolving Treatment Paradigm
1.5 Credits / Gastroenterology, Immunology
View More
Addressing the Challenges of Treating Moderate to Severe Atopic Dermatitis With Targeted Biologic Therapies in...
1.5 Credits / Allergy, Dermatology, Immunology
View More
Dual Inhibition in the Management of Moderate to Severe Asthma: Selecting the Appropriate Biologic Therapy Bas...
1.5 Credits / Allergy, Pulmonology, Immunology
View More
Understanding GOLD Updates and Role of Emerging Biologics in COPD Management
1.0 Credit / Immunology, Pulmonology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Utilizing the Pharmacist to Improve Patient Outcomes in COPD
1.0 Credit / Immunology, Pulmonology
View More
Foundations in the Management of Eosinophilic Esophagitis: Pathophysiology, Clinical, Economic, and Quality of...
1.0 Credit / Gastroenterology, Immunology
View More
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
1.0 Credit / Gastroenterology, Immunology, Rare Diseases
View More
The Evolving Treatment Paradigm for the Management of Eosinophilic Esophagitis and the Future of Oral Therapie...
1.0 Credit / Gastroenterology, Immunology
View More
The Role of the Community Pharmacist in the Management of Eosinophilic Esophagitis
1.0 Credit / Gastroenterology, Immunology
View More
Intravenous Immunoglobulin Preparations Leads to Varied Effects in Patients With Kawasaki Disease
August 6th 2024Two different brands of intravenous immunoglobulin have been investigated, finding Brand P led to significantly longer durations of fever and hospitalization when compared to brand T.
Read More
Severe Pemphigus Vulgaris Successfully Treated With Intravenous Immunoglobulin
July 17th 2024A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.
Read More
High-Dose Intravenous Immunoglobulin Responsive to Platelet-Activating Anti-PF4 Disorder
July 11th 2024Intravenous immunoglobulin was effective as an adjunctive treatment to anticoagulation in a patient with post-viral platelet-activating anti-PF4 disorder, indicating the need for accurate diagnosis and treatment selection.
Read More
IVIG, Plasmapheresis Effective in Managing Non-Tumor Anti-Tr/DNER Antibody-Associated Ataxia
July 2nd 2024In a rare case of non-tumor anti-Tr/DNER antibody-associated ataxia, the patient is treated with plasmapheresis and intravenous immunoglobulin (IVIG) for symptoms such as dysarthria and difficulty walking.
Read More
Large Review Suggests IVIG is Effective for Neurological Diseases Following COVID-19 Infection
September 27th 2023Intravenous immunoglobulin found to provide fast and long-lasting relief for COVID-19-related neurological conditions, although investigators are still uncovering the pathology of many of these conditions.
Read More